Appreciate the Musella Foundation / @VirtualTrials further highlighting the Phase 1 results for oral gallium maltolate in recurrent #GBM:
https://t.co/vgKlCuC5rJ
Strong safety profile + OS ~16 months, with long-term survivors >30 months. Early data—but highlights the value of continuing innovation in this space. Encouraging early signal in a difficult disease.
#glioblastoma #neurooncology #braincancer #clinicaltrials
@piersmorgan@_DeclanRice Jee wiz Morgan we all know that the fixed prem title plays 2nd fiddle to the Prem league player of the season title . Bruuunooo